8legs: Oxford university researchers

#1 out of 1

UK scientists developing Ebola vaccine that could be ready for trials in months

Oxford University researchers are developing an Ebola vaccine that could begin clinical trials in two to three months.
The outbreak centers on the Democratic Republic of Congo, with 750 suspected cases and 177 deaths.
The vaccine targets Bundibugjo Ebola, a rare strain with no proven vaccine.
The UK team uses a ChAdOx1 platform, a technology refined during the Covid-19 pandemic.
Animal testing is underway in Oxford to gather data on safety and efficacy.
The Serum Institute of India is lined up to mass produce the vaccine once material is ready.
World Health Organization has upgraded the outbreak risk to very high in the DRC.
Bundibugoro vaccination uses ring vaccination to protect those most at risk.
Oxford researchers are building on prior work against Sudan Ebola and Marburg viruses.
The WHO declared a public health emergency of international concern earlier this week.

Vote 0